Lonitoclax
Lonitoclax is a B-cell lymphoma 2 (Bcl-2) inhibitor. Lonitoclax has comparable anti-tumor efficacy to Venetoclax (HY-15531) in both B cell and myeloid malignancy models. Lonitoclax is promising for research of relapsed or refractory chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma, and certain low-grade lymphomas.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- CAS No.: 2952589-57-8
- Formule: C43H45ClN4O5
- Masse moléculaire:733.29
-
Stockage:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Activité biologique
-
Chemical Information
- Pureté et documentation
- Références
-
Help & FAQs
Activité biologique
Chemical Information
-
CAS No. 2952589-57-8
-
Masse moléculaire 733.29
-
Formule C43H45ClN4O5
-
SMILES
O=C(N1[C@@H](CC2=CC=CC=C2C1)CN3CCOCC3)C4=C(C5=CC(C(N(C6=CC=C(C=C6)O)CC7=C(C(OC)=CC=C7)C)=O)=C(N5C)C)C=C(C=C4)Cl
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureté et documentation
Références
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Lonitoclax Related Classifications
HY-168983 Related Classifications
Powered by Bioz